Biosimilars for the Treatment of Cancer: A Systematic Review of Published Evidence

BACKGROUND: Biologic treatments for cancer continue to place a significant economic burden on healthcare stakeholders. Biosimilar therapies may help reduce this burden through cost savings, thereby increasing patient access. OBJECTIVES: The purpose of this study was to collate all published data to...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Ira, Ewesuedo, Reginald, Lula, Sadiq, Zacharchuk, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258783/
https://www.ncbi.nlm.nih.gov/pubmed/28078656
http://dx.doi.org/10.1007/s40259-016-0207-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258783/
https://www.ncbi.nlm.nih.gov/pubmed/28078656
http://dx.doi.org/10.1007/s40259-016-0207-0

Ejemplares similares